Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Hyperthermia in cancer growth regulation

  • 42 Accesses

  • 7 Citations

Abstract

With present techniques, hyperthermia used alone can cause complete clinical regression in 10–15% of tumours but the duration of response is very short. The greatest advantage for hyperthermia at the present time appears to be in combination with radiation in the local control of cancer growth. Currently, large randomised phase III studies are in progress to determine whether the addition of local hyperthermia to radiation or chemotherapy yields significant advantage. Phase III studies of wholebody hyperthermia in combination with chemotherapy are planned for the future and will include tumours with a high growth fraction such as small cell lung cancer and high grade non Hodgkins lymphoma.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Field SB, Hand JE, eds. An Introduction to the practical aspects of clinical hyperthermia. London: Pub. Taylor and Francis, 1990.

  2. 2.

    Field SB, Vernon CC. Hyperthermia. In: Sikora K, Halnan K, eds. Cancer therapy. London: Chapman & Hall, 1989: 105–26.

  3. 3.

    Field SB, Franconi C, eds. Physics and technology of hyperthermia. Dordrecht: Pub. Martinus Nijhoff, 1987.

  4. 4.

    Overgaard J, ed. Hyperthermic oncology 1984, Vols 1 & 2. London & Philadelphia: Taylor & Francis, 1985.

  5. 5.

    Issels RD, Wilmanns W, eds. Application of hyperthermia in the treatment of cancer. In: Recent results in cancer research, Vol 7, Berlin: Springer Verlag, 1988.

  6. 6.

    Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia 1986; 2: 111–37.

  7. 7.

    Song CW. Effect of local hyperthermia on blood flow and microenvironment. A review: Cancer Res. (Suppl) 1984; 44: 4721s-30s.

  8. 8.

    Kallman RJ. The phenomenon of reoxygenation and its complications for fractionated radiotherapy. Radiol 1972; 105: 135–42.

  9. 9.

    Hahn GM. Metabolic aspects of the role of hyperthermia in mammalian cells inactivation and their possible relevance to cancer treatment. Cancer Res 1974; 34: 311–723.

  10. 10.

    Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiotherapy and Oncology 1984; 2: 343–66.

  11. 11.

    Leeper DB. Molecular and cellular mechanisms of hyperthermia alone or combined with other modalities. In: Overgaard J, ed. Hyperthermic Oncology, 1984. London, New York and Phil: Taylor and Francis, 1985, Vol 2: 9–40.

  12. 12.

    Roti-Roti JL, Wilson CF. The effects of alcohols, procaine and hyperthermia on the protein content of nuclei and chromatin. Int J Radiat Biol 1984; 46: 35–43.

  13. 13.

    Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiol 1977; 123: 464–74.

  14. 14.

    Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Physics 1984; 10: 787–800.

  15. 15.

    Raaphorst GP, Azzam EI, Borsa J, Einspenner M. Hyperthermia in a differentiating murine erythroleukemia cell line. I. cell killing by heat and radiation. Int J Radiat Biol 1983b; 44: 275–83.

  16. 16.

    Li GC, Mivechi NF. Thermotolerance in mammalian systems: a review. In: Anghilieri LJ, Robert J, eds. Hyperthermia in cancer treatment. Boca Raton: CRC Press, 1986, Vol 1: 59–77.

  17. 17.

    Westra A, Dewey WC. Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cellsin vitro. Int J Radiat Biol 1971; 19: 467–77.

  18. 18.

    Raaphorst GP, Freeman ML, Dewey WC. Radiosensitivity and recovery from damage in cultured CHO cells exposed to hyperthermia at 42.5 or 45.5°C. Radiat Res 1979a; 390–402.

  19. 19.

    Henle KJ. Heat Protectors of mammalian cells. In: Henle KJ, ed. Thermotolerance, mechanisms of heat resistance. Boca Raton: CRC Press, 1987a; Vol 2: 127–43

  20. 20.

    Hand JW, James J, eds. Physical techniques in clinical hyperthermia. Research Studies Press, 1986.

  21. 21.

    Perez CA, Kuske RR, Emami B, Fineberg B. Irrdiation alone or combined with hyperthermia in the treatment of recurrent carcinoma of the breast in the chest wall: a non randomized comparison. Int J Hyperthermia 1986; 2: 179–87.

  22. 22.

    Sapozink MD, Gibbs FA, Egger MJ, Stewart JR. Regional hyperthermia for clinically advanced deep-seated pelvic malignancy. American J of Clinical Oncology 1986; 9: 162–9.

  23. 23.

    Storm FK, Baker HW, Scanlon EF, Plenck HP, Meadows PM, Cohen SC, Olson CE, Thompson JW, Khandekar JD, Roe D, Nizze A, Morton DL. Magnetic induction hyperthermia. Results of a 5-year muti-institutional national cooperative trial in advanced cancer patients. Cancer 1985; 55: 2677–87.

  24. 24.

    Howard GCW, Sathiaseelen V, King GA, Dixon AK, Anderson A, Bleehen HM. Regional hyperthermia for extensive pelvic tumours using annular based array applicator: a feasibility study. Br J Radiol 1986; 59: 1195–201.

  25. 25.

    Shimm DS, Cetas TC, Oleson JR, Cassady JR, Sim DA. Clinical evaluation of hyperthermia equipment: The University of Arizona Institutional Report for the NCI Hyperthermia Equipment Valuation Contract. Int J Hyperthermia 1988. 1971.

  26. 26.

    Strobehn JW. Interstitial techniques for hyperthermia. In: Field SB, Franconi C, eds. Physics & technology of hyperthermia. Dordrecht: Martinus Nijhoff, 1987: 211–39.

  27. 27.

    Emami B, Perez CA. Interstitial thermoradiotherapy: an overview. Hyperthermia Oncology 1985; 1: 35–40.

  28. 28.

    van der Zee J, Faithfull NS, van Rhoon GC, Rheinnhold HS. Whole body hyperthermia as a treatment modality. In: Field SB, Franconi C, eds. Dordrecht: Martinus Nijhoff, 1987: 420–40.

  29. 29.

    Cetas TC. Thermometry. In: Field SB, Franconi C, eds. Physics & technology of hyperthermia. Dordrecht: Martinus Nijhoff, 1987, 470–508.

  30. 30.

    Fajardo L. Pathological effects of hyperthermia in normal tissues. Cancer Res (supl) 44: 4826s–35s.

  31. 31.

    Law MP, Ahier RG, Field SB. The response of the mouse ear to heat applied alone or combined with x-rays. Brit J Radiol 1978; 51: 132–8.

  32. 32.

    Field SB, Morris CC. Experimental studies of thermotolerancein vivo. 1. The baby rat tail model. Int J Hyperthermia 1985; 1: 236–46.

  33. 33.

    Li GC, Laszlo A. Thermotolerance in mammalian cells: a possible role for heat shock proteins. In: Atkinson BG, Walden DB, eds. Changes in gene expression in response to environmental stress. New York: Academic Press, 1985: 227.

  34. 34.

    Field SB. Clinical implications of thermotolerance. In: Overgaard J., ed. Hyperthermic oncology. London, New York and Philadelphia: Taylor and Francis, 1985, 2: 235–44.

  35. 35.

    Dunlop PRC, Hand JW, Dickinson RJ, Field SB. An assessment of local hyperthermia in clinical practice. Int J Hyperthermia 1986; 2: 39–50.

  36. 36.

    Overgaard J, Overgaard M. Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma. Int J Hyperthermia 1987; 3: 483–502.

  37. 37.

    Henle KJ. Sensitization to hyperthermia below 43°C induced in Chinese hamster ovary cells by step-down heating. J Nat Cancer Inst 1980; 68: 1033–6.

  38. 38.

    Overgaard J. The design of clinical trials in hyperthermic oncology. In: Overgaard J, ed. Hyperthermic oncology 1984. London, New York and Philadelphia: Taylor & Francis, 1985: 325–8.

  39. 39.

    Sapozink MD, Astrahan M, Boyd S. Treatment of benign prostatic hyperplasia with transurethral hyperthermia. In: Abstract Ad-9, Thirty seventh Annual Meeting of the Radiation Research Society, Seattle, Washington DC. 1989.

  40. 40.

    Lindholm CE, Kjellen E, Nilsson P. Low dose radiotherapy with and without hyperthermia in superficial human tumours with evaluation of prognostic factors for tumour response. In: Sugahara T, Saito M, eds. Hyperthermic oncology 1988. London, New York and Philadelphia: Taylor & Francis, 1989: 618–20.

  41. 41.

    Gonzalez Gonzalez D, van Dijk JDP, Blank LECM. Chest wall recurrences of breast cancer: results of combined treatment with radiation and hyperthermia. Radiotherapy and Oncology 1988; 12: 95–103.

  42. 42.

    Overgaard J. The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol and Physics 1989a; 16: 535–49.

  43. 43.

    Arcangeli G, Benassi M, Cividalli A, Lovisolo GA, Mauro F. Radiotherapy and hyperthermia. Analysis of clinical results and identification of prognostic variables. Cancer 1987; 60: 950–6.

  44. 44.

    Valdagni R, Liu FF, Kapp DS. Important prognostic factors influencing outcome of combined radiation and hyperthermia. Int J Radiat Oncol Biology and Physics 1988b; 15: 959–72.

  45. 45.

    Hofman P, Knol RGF, Legendijk JJW, Schipper J. Thermoradiotherapy of primary breast carcinoma. Int J Hyperthermia 1989; 5: 1–11.

  46. 46.

    Suit HD. Potential for improving survival rates for cancer patients by improving efficiency of treatment of primary lesion. Cancer 1982; 50: 1227–34.

  47. 47.

    Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990; 479–86.

  48. 48.

    Muratkhodzhaev NK, Svetitsky PV, Kochegarov AA, Alimnazarov ShA, Kuznetzov VN, Shek BA. Hyperthermia in therapy of cancer patients (in Russian). Medical Radiology 1987; 32: 30–6.

  49. 49.

    Kapp DS. Site and disease selection for hyperthermic clinical trials. Int J Hyperthermia 1986; 2: 139–56.

  50. 50.

    Dewhirst MW, Sim DA. The utility of thermal dose as a predictor of tumour and normal tissue responses to combined radiation and hyperthermia. Cancer Research 1984; 44s: 4772s-80s.

  51. 51.

    Molls N, Sacherer E. The combination of hyperthermia and radiation: clinical investigations. In: Streffer C, ed. Hyperthermia and the therapy of malignant tumours. Berlin: Springer Verlag, 1987: 110–35.

  52. 52.

    Hynynen K, Shimm D, Anhalt D, Stea B, Sykes H, Cassady HR, Roemer RB. Temperature distributions during clinical scanned, focused ultrasound hyperthermia treatments. Int J Hyperthermia 1990; Vol 6, 5: 891–908.

  53. 53.

    Field SB. Studies relevant to a means of quantifying the effects the effects of hyperthermia. Int J Hyperthermia 1987; 3: 291–6.

  54. 54.

    Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Physics 1984; 10: 787–800.

  55. 55.

    Dahl O. Interaction of hyperthermia and chemotherapy. Recent Results in Cancer Research 1988; 107: 157–69.

  56. 56.

    Herman TS, Teicher BA, Jochelson M, Clark J, Svennson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988b; 4: 143–58.

  57. 57.

    Bull JMC. A review of systemic hyperthermia. In: Frontiers of radiation therapy and oncology 1984. Basel: Karger, 1984: 171–6.

  58. 58.

    Engelhardt R. Hyperthermia and drugs. Recent Results in Cancer Research 1987; 104: 136–204.

  59. 59.

    Krementz ET. Chemotherapy by isolated regional perfusion for melanoma of the limbs. Recent Results in Cancer Research 1983; 86: 193–203.

  60. 60.

    Bassett JB, Anderson RU, Tacker JR. Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumour. Journal of Urology 1986; 135: 612–5.

  61. 61.

    Arcangeli G, Cividalli A, Mauro F, Nervi C, Pavin G, Enhanced effectiveness of adrimycin and bleomycin combined with local hyperthermia in neck node metastases from head and neck cancers. Tumori 1979; 65: 441–86.

  62. 62.

    Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens LC, Bull JMC. Effect of cisdiamminedichloroplatinimum (II) combined with wholebody hyperthermia on renal injury. Cancer Research 1988; 48: 440–6.

  63. 63.

    European Society for Hyperthermic Oncology. European Society for Hyperthermic Oncology Protocols, 3rd ed. Study Co-ordinator: J. Overgaard, Institute of Cncer Research, DK-8000 AArhus C.

  64. 64.

    Medical Research Council MRC Phase III trial (January 1989). Trial co-ordinator: CC Vernon, Hammersmith Hospital, London.

  65. 65.

    RTOG. Phase III Superficial Tumour Study, 1990. Trial coordinator: Perez C, Mallinckrodt Inst. MO 63108, USA.

  66. 66.

    Herman TS, Teicher BA, Jochelsen M, Clark J, Svensson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988; 4: 143–8.

  67. 67.

    Jirtle RL. Chemical modifications of tumour blood flow. Int J Hyperthermia 1988; 4: 4, 355.

  68. 68.

    Wilson C, Vernon CC, Lammertsma AA, Jones T. Vascular changes in tumours following hyperthermia, monitored using PET. Abstract. 11th Conference of ESHO, Latina, 1990. In: Strahlentherapie and Onkologie, Urban & Vogel, 1990: 538.

  69. 69.

    Lagendijk JJW, Nillsson P. Hyperthermia dough: a fat and bone equivalent phantom to test microwave/radiofrequency hyperthermia heating systems. Physics in Medicine and Biology 1985; 30(7): 709–12.

  70. 70.

    Dewhirst MW, Phillips TL, Samulski TV, Stauffer P, Shrivastava P, Paliwal B, Pajak T, Gillim M, Sapozink M, Myerson R, Waterman FM, Sapareto SA, Corry P, Cetas TC, Leeper DB, Fessenden P, Kapp D, Oleson JR, Emami B. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Physics 1990 (in press).

  71. 71.

    Martin CJ. Temperature measurement in tissue by invasive and non-invasive techniques. In: Watmough DJ, Ross WM, eds. Hyperthermia. London: Blackie, 1986:154–79.

  72. 72.

    Cetas TC. Will thermometric tomography become practical for hyperthermia monitoring? Cancer Research 1984; 44s: 4805s-8s.

  73. 73.

    Lagendijk JJW, Mooibroek J. Hyperthermia treatment planning. Recent Results in Cancer Research 1986; 101: 18–35.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vernon, C. Hyperthermia in cancer growth regulation. Biotherapy 4, 307–315 (1992). https://doi.org/10.1007/BF02172661

Download citation

Key words

  • cancer regulation
  • hyperthermia